Inventiva (IVA) Enterprise Value (2018 - 2025)
Inventiva (IVA) recorded quarterly Enterprise Value of -$268.7 million in Q4 2025, down 22.2% quarter-over-quarter from -$219.9 million in Q2 2025, and down 160.33% on a YoY basis from $445.4 million in Q4 2024.
Inventiva (IVA) Enterprise Value (2018 - 2025) Analysis & Trends
Inventiva's Enterprise Value history runs 8 years deep, the most recent figure standing at -$268.7 million for Q4 2025.
- In Q4 2025, Enterprise Value fell 160.33% year-over-year to -$268.7 million; the TTM figure through Dec 2025 stood at -$268.7 million (down 160.33% YoY), while the FY2025 annual figure was -$268.7 million, down 160.33% from the prior year.
- Enterprise Value was -$268.7 million for Q4 2025 at Inventiva, down from -$219.9 million in the prior quarter.
- In the past five years, Enterprise Value ranged from a high of -$9.7 million in Q4 2023 to a low of -$268.7 million in Q4 2025.
- Historically, Enterprise Value has averaged -$107.0 million across 5 years, with a median of -$99.0 million in 2021.
- The sharpest annual moves came in 2023 and 2024: Enterprise Value jumped 88.99% in 2023, then plunged 959.53% in 2024.
- A 5-year view of Enterprise Value shows it stood at -$99.0 million in 2021, then grew by 10.63% to -$88.5 million in 2022, then surged by 88.99% to -$9.7 million in 2023, then slumped by 959.53% to -$103.2 million in 2024, then plunged by 160.33% to -$268.7 million in 2025.
- The last three Enterprise Value figures came in at -$268.7 million (Q4 2025), -$219.9 million (Q2 2025), and -$103.2 million (Q4 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 788,338.31 Bn | 788,338.28 Bn | - | -32.30 Mn |
| 2 | Belite Bio | 56,560.00 Bn | 56,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,329.30 Bn | 17,329.30 Bn | - | -4.14 Mn |
| 4 | Legend Biotech | 3,341.00 Bn | 3,340.71 Bn | 242.10 Mn | -286.70 Mn |
| 5 | Akari Therapeutics | 1,727.91 Bn | 1,727.91 Bn | - | -2.77 Mn |
| 6 | Evaxion A | 1,536.68 Bn | 1,536.67 Bn | - | -18.44 Mn |
| 7 | Psyence Biomedical | 238.34 Bn | 238.33 Bn | - | -7.20 Mn |
| 8 | Vertex Pharmaceuticals | 113.42 Bn | 106.17 Bn | 2.59 Bn | -7.25 Bn |
| 9 | Abivax | 95.45 Bn | 95.45 Bn | - | -584.73 Mn |
| 10 | Inventiva | 8.93 Mn | -259.80 Mn | - | -268.73 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -268.73 Mn |
| Jun 30, 2025 | -219.92 Mn |
| Dec 31, 2024 | -103.23 Mn |
| Jun 30, 2024 | -43.60 Mn |
| Dec 31, 2023 | -9.74 Mn |
| Oct 11, 2023 | -12.54 Mn |
| Jun 30, 2023 | -105.20 Mn |
| Dec 31, 2022 | -88.49 Mn |
| Sep 22, 2022 | -90.31 Mn |
| Jun 30, 2022 | -92.36 Mn |
| Dec 31, 2021 | -99.01 Mn |
| Jun 30, 2021 | -127.28 Mn |
| Mar 31, 2021 | -130.04 Mn |
| Dec 31, 2020 | -126.01 Mn |
| Jun 30, 2020 | -57.58 Mn |
| Mar 31, 2020 | -51.77 Mn |
| Dec 31, 2019 | -39.67 Mn |
| Dec 31, 2018 | -64.71 Mn |